Navigation Links
InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
Date:8/7/2008

BRITISH COLUMBIA, Canada, Aug. 7 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (TSX: IXS.V; OTC Bulletin Board: IXSBF) (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announced today that it has launched a large scale primate study of DXL625 (CD20), the company's lead program.

"We are beginning a study in cynomolgus monkeys of DXL625, an antibody directed against the B-cell marker CD20 and enhanced in potency with our DXL(TM) technology," said Thomas Kindt, Ph.D., Chief Scientific Officer. "The test is designed to evaluate toxicity and pharmokinetics of our product and to measure B-cell depletion and recovery in this primate species. This study, which takes multiple months to complete and is part of our drug development plan will generate data moving us toward human clinical trial testing with DXL625."

"Our scientific team has made steady progress in the rapid development of our first preclinical candidate, DXL625 for the prospective treatment of Non-Hodgkin's Lymphoma," said Jeff Morhet, CEO and Chairman. "The primate study is being conducted by Covance Inc. within their world-class facilities in Wisconsin. The launch of this study marks a significant milestone achievement for the company and our lead product DXL625."

InNexus recently announced the addition of a new product designated DXLr120 (CD20). This is the third product added to the growing InNexus pipeline and was developed using new recombinant methods to produce a DXL(TM) anti-CD20 antibody. Upon questions regarding InNexus having a franchise of CD20 products using multiple methods of creation, chemical and recombinant, CEO Morhet said, "I would also think that these products could and should be bundled toward future collaborations with pharmaceutical companies and DXLr120 was developed within our part
'/>"/>

SOURCE InNexus Biotechnology Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
2. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
3. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
4. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
5. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
6. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
7. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
8. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
9. Leading Biotechnology Company Grows with StayinFront CRM
10. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
11. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ll/ - Microbix Biosystems Inc. (the "Company") ann...1 Certification of Annual Filings of William Gastl... Chief Financial Officer (the "Officer,s Certifica...e annual audited financial statements for the year...ally filed the annual financial statements for the...
(Date:11/6/2009)...-- Myriant Technologies LLC ("Myriant"), a private...newable bio-chemicals, Uhde Corporation of America...one of the world,s leading engineering contractors...ngineering, procurement & construction (EPC) o... renewable feedstocks. The execution of this alli...
(Date:11/6/2009)...wswire/ -- Calbiotech, Inc. announced today that i...earch (SBIR) Phase I contract by the U.S. Army Med... the agreement, Calbiotech will develop analyte sp... virus. ,, Dengue virus is a mosquito-born f...ry forces deployed to tropical areas of the world....
(Date:11/6/2009)...Arrowhead’s 2010 Personalized Medicine Partn...February 22-24, 2010 in Philadelphia, has been ann...ight key issues in forming partnerships and engage... Minneapolis, MN (PRWEB) No... 2010 Personalized Medicine Partnerships Conferen...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...Jan. 7 Volcano Corporation,(Nasdaq: VOLC ), a l...of,products for the diagnosis and treatment of cor...at it has closed its previously announced acquisit...eading developer and manufacturer of lasers and op...mography (OCT) imaging systems and,advanced photon...
...logy Index Shows Stronger Performance in Turbulent... the nation,s largest high-tech trade association ...y, announced today that the NASDAQ OMX AeA Illinoi...w Jones Industrial Average (.INDU), S&P 500, a...ption in 2008. , , On May 19, 2008, AeA and The N...
... GlaxoSmithKline plc (LSE/NYSE: GSK ) announced ...r by its wholly-owned subsidiary Gemstone Acquisit...labs Technologies, Inc. (Nasdaq: GNLB ). The ten... time, on Tuesday, January 6, 2009. , , The depos...areholders of Genelabs have tendered and not withd...
Other Biology Technology:Volcano Announces Closing of Axsun Technologies Acquisition 2NASDAQ OMX AeA Illinois Tech Index Outperforms Market 2NASDAQ OMX AeA Illinois Tech Index Outperforms Market 3GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc. 2
(Date:11/9/2009)...nary biologists David Queller and Joan Strassmann ... conflict between components, from the genetic lev... whether that thing is an animal, a plant, a bacte...s use to describe an organism, such as individuali... be necessary to achieve organismality. What is ne...
(Date:11/9/2009)...ov. 9 Genencor, a division of Dani...d" from the American Institute of Chemical Enginee...ymes for cellulosic ethanol. Yesterday, Robert Dav... the award to Landon Steele, who is Marketing Dire...t Manager, and Aaron Kelley, who is Senior Enginee...
(Date:11/9/2009)...9, 2009 A nutritionist whose research was instrum...al Women, Infants and Children (WIC) food subsidy ...d for outstanding achievement in the field of mate...MNS, , a professor in the Department of Community ...os Angeles School of Public Health, will receive t...
Breaking Biology News(10 mins):What is the meaning of 'one'? 2What is the meaning of 'one'? 3Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Many Cancer Survivors Dont Adopt Healthy Lifestyle 52815 1Many Cancer Survivors Dont Adopt Healthy Lifestyle 52815 2Sprouts Farmers Market Sprouts New Location in Orange 52812 1Sprouts Farmers Market Sprouts New Location in Orange 52812 2Paradigm Spine Closes 2421 5 Million Financing and Announces Promotion of Matt Stuttle to Position of Vice President US Sales 52809 1Paradigm Spine Closes 2421 5 Million Financing and Announces Promotion of Matt Stuttle to Position of Vice President US Sales 52809 2Paradigm Spine Closes 2421 5 Million Financing and Announces Promotion of Matt Stuttle to Position of Vice President US Sales 52809 3
...ug used experimentally in HIV therapy, greatly inc...ystem T cells in some HIV-positive people who resp...he National Institutes of Health (NIH) Clinical Ce...ectious Diseases (NIAID), part of the NIH. A repor...’s Joseph A. Kovacs, M.D., appears online today in...
... United States during the summer of 2003 didn,t pr...sually kills 10 percent of those infected. , Why ...int Louis University Health Sciences Center and se..., In this month,s issue of Virology, researcher an...is University Health Sciences Center and colleague...
...a monocytogenes, which causes a major food-borne ...to invade cells and hide from the body,s immune sy... may use the same mechanism. , The Listeria bac...d to humans via undercooked and unpasteurized food...stress. For individuals with weakened immune syste...
Other Biology News:HIV Therapy Greatly Extends Life of Key T Cells, Scientists Find 2HIV Therapy Greatly Extends Life of Key T Cells, Scientists Find 3Monkeypox mystery: New research may explain why 2003 outbreak in the US wasn't deadly 2Gene discovery sheds light on causes of rare disease, cancer 2
Goat Anti-cystatin A (N-18) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Afe I from New England Biolabs
...bes is pleased to offer the ATTO-TAG series of rea...amines. Developed by Novotny and collaborators at ...lar to the important reagents o-phthaldialdehyde (...nthracene-2,3-dicarboxaldehyde, all of which are a...
Mouse Anti-Human Troponin I Monoclonal Antibody, Unconjugated, Clone 12F10 from ABR-Affinity BioReagents
Biology Products: